Host: Peter Buch, MD, FACG, AGAF, FACP <br> Guest: Alexa Weingarden, MD PhD <br> <article data-scroll-anchor="true" data-testid="conversation-turn-10" data-turn="assistant" data-turn-id="request-WEB:5e483d80-d8b0-430d-b576-728e4a074982-4" dir="auto" tabindex="-1"> <div> <div tabindex="-1"> <div> <div data-message-author-role="assistant" data-message-id="305ce8a9-d839-4dec-8718-be35f21c89ea" data-message-model-slug="gpt-4o" dir="auto"> <div> <div> <p data-end="646" data-is-last-node="" data-is-only-node="" data-start="129">Probiotic use in gastroenterology remains a complex and evolving topic, shaped by variable evidence and growing patient demand. Dr. Peter Buch sits down with Dr. Alexa Weingarden to review current data, discuss distinctions between probiotic-related therapies, and explore the clinical utility of microbiome testing. Dr. Weingarden is an Assistant Professor of Gastroenterology, Hepatology, and Nutrition at the University of Minnesota Medical School.</p> </div> </div> </div> </div> </div> </div> </article>

GI Insights

ReachMD

Probiotics in GI Practice: Evidence, Guidelines, and Emerging Innovations

OCT 1, 202513 MIN
GI Insights

Probiotics in GI Practice: Evidence, Guidelines, and Emerging Innovations

OCT 1, 202513 MIN

Description

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Alexa Weingarden, MD PhD

Probiotic use in gastroenterology remains a complex and evolving topic, shaped by variable evidence and growing patient demand. Dr. Peter Buch sits down with Dr. Alexa Weingarden to review current data, discuss distinctions between probiotic-related therapies, and explore the clinical utility of microbiome testing. Dr. Weingarden is an Assistant Professor of Gastroenterology, Hepatology, and Nutrition at the University of Minnesota Medical School.